This inventor holds 2 USPTO granted patents. Top assignees: Daicel Chemical Industries, Ltd., Sapporo Breweries Limited, Etsuo Ito. Active years: 1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1982
Title: Shigeyoshi Kato: Innovator in Polysaccharide Research
Introduction
Shigeyoshi Kato is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of polysaccharide research, particularly in the development of substances derived from rice bran. With a total of 2 patents, Kato's work has implications for medical applications, especially in the area of anti-tumor agents.
Latest Patents
Kato's latest patents include a process for the production of a polysaccharide RBS substance. This substance is obtained from rice bran through extraction with hot water. The polysaccharide RBS substance has been identified as having potential as an antitumor agent. Another patent details the characteristics of the polysaccharide RBS substance, which exhibits specific ultraviolet and infrared absorption spectra. These substances have been tested for anti-tumor activity against Sarcoma 180 ascites tumor and Ehrlich ascites tumor, demonstrating effectiveness in combating these tumors.
Career Highlights
Throughout his career, Kato has worked with prominent companies such as Sapporo Breweries Limited and Daicel Chemical Industries, Ltd. His experience in these organizations has contributed to his expertise in the field of polysaccharide research.
Collaborations
Kato has collaborated with notable coworkers, including Eichi Soma and Kohei Kobayashi. Their joint efforts have further advanced the research and development of polysaccharide substances.
Conclusion
Shigeyoshi Kato's innovative work in polysaccharide research highlights the potential of rice bran-derived substances in medical applications. His contributions continue to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile